Where are we now with hormone replacement therapy?

Area of Science:

• Endocrinology
• Pharmacology
• Women's Health

Background:

• Hormone replacement therapy (HRT) has been widely used since the 1950s to manage menopausal symptoms.
• Growing evidence has raised concerns about the risks and side effects associated with long-term HRT use.
• Biological theories have limitations in predicting HRT's effects on cancer and cardiovascular disease.

Purpose of the Study:

• To review decades of evidence on hormone replacement therapy.
• To assess the efficacy and safety of HRT for menopausal symptom management and long-term health.
• To examine the reliability of observational studies versus randomized clinical trials in drug evaluation.

Main Methods:

• Review of accumulated evidence and clinical trial data on hormone replacement therapy.
• Analysis of the limitations of current biological theories in predicting HRT outcomes.
• Examination of the influence of market forces and vested interests on drug prescription and evaluation.

Main Results:

• Hormone replacement therapy is effective for menopausal symptoms but not for improving future health outcomes.
• Observational studies on drug effects, particularly for coronary disease, are often unreliable.
• Significant and unanticipated side effects of medications can take decades to reliably detect.

Conclusions:

• Scientific independence is crucial for genuine women's healthcare, as uncertainty can be exploited by vested interests.
• Current regulatory frameworks may not be sufficient to prevent tragic medication-related episodes.
• Lessons learned from HRT and past drug safety issues, like thalidomide, are critical for future drug marketing and regulation.